Older adults respond well to immunotherapy despite age-related immune system differences
Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns Hopkins…
Covid e terapia con plama. OneBlood diventa il primo centro ematologico a ricevere l’ approvazione della FDA
OneBlood, il centro ematologico senza scopo di lucro che serve gran parte del sud-est degli Stati Uniti, è diventato il primo centro ematologico del Paese a ricevere l’approvazione completa della…
Flu, a chip to measure immunity
Every winter, influenza returns with a new variant. People who have previously been infected with or vaccinated against flu may have some protection, but this depends on how well their…